TP53 and liver cancer: To establish the causative relationship between aberrant β-catenin activation and liver cancer, we not only dissected the role of CTNNB1 mutation alone in liver carcinogenesis but also demonstrated its collusion with Tp53 deletion or transgenic HBV in liver cancer propagation.